Zepto Life Technology
Zepto Life Technology is dedicated to improving diagnostic standards and advancing patient outcomes worldwide through innovative molecular diagnostics and regulatory support. They focus on highly sensitive, multiplexed, and automated diagnostic platforms, supporting FDA regulatory submissions and clinical testing services.
Industries
Nr. of Employees
small (1-50)
Zepto Life Technology
1000 Westgate Drive, Suite 2000 St. Paul, MN 55114
Patents
System and method for processing analyte signals in GMR-based detection of biomarkers
US-12241851-B2
View DetailsSystem and method for sample preparation in GMR-based detection of biomarkers
US-11639908-B2
View Details
System and method for processing analyte signals in GMR-based detection of biomarkers
US-12241851-B2
View DetailsSystem and method for sample preparation in GMR-based detection of biomarkers
US-11639908-B2
View DetailsProducts
Multiplex fungal detection panel for invasive fungal infections
A multiplex molecular panel designed to detect a broad set of invasive fungal pathogens with reported high sensitivity; intended for rapid detection to support clinical decision-making (platform not marketed in the U.S. per site disclaimer).
Multiplex fungal detection panel for invasive fungal infections
A multiplex molecular panel designed to detect a broad set of invasive fungal pathogens with reported high sensitivity; intended for rapid detection to support clinical decision-making (platform not marketed in the U.S. per site disclaimer).
Services
High-complexity CLIA laboratory testing services for clinical samples, including a broad test menu focused on sexually transmitted infections (STIs) and respiratory pathogens; services include trained staff, customized client reports, and rapid turnaround.
Contract research organization services covering analytical study design and execution, product validation, regulatory strategy and submission support (including FDA EUA and 510(k)), clinical trial support (study management, biostatistics, data management), QMS development, and LDT capabilities within onsite CLIA and BSL 2+ facilities.
R&D and assay development services focused on magnetic sensing lab-on-chip platforms designed for high-sensitivity, high-plex molecular detection with rapid turnaround suitable for point-of-care or near-patient applications.
High-complexity CLIA laboratory testing services for clinical samples, including a broad test menu focused on sexually transmitted infections (STIs) and respiratory pathogens; services include trained staff, customized client reports, and rapid turnaround.
Contract research organization services covering analytical study design and execution, product validation, regulatory strategy and submission support (including FDA EUA and 510(k)), clinical trial support (study management, biostatistics, data management), QMS development, and LDT capabilities within onsite CLIA and BSL 2+ facilities.
R&D and assay development services focused on magnetic sensing lab-on-chip platforms designed for high-sensitivity, high-plex molecular detection with rapid turnaround suitable for point-of-care or near-patient applications.
Expertise Areas
- Molecular diagnostics development
- Point-of-care and rapid diagnostic assay development
- Central reference laboratory testing (CLIA high-complexity)
- Analytical validation and performance testing
Key Technologies
- Giant magnetoresistance (magnetic sensing) for molecular detection
- Lab-on-a-chip platforms
- Magnetic nanoparticle-based assay reagents
- Multiplexed sensor arrays (high-plex detection)
News & Updates
A collaborative study between Zepto Life Technology and the University of Minnesota on improving monitoring of fungal infections.
Zepto announced a critical study presentation at ECCMID in April 2024.
Zepto formed an advisory board with industry experts in infectious diseases and molecular diagnostics.
Zepto announced the successful closing of its Series A funding round from Huimei Healthcare.
Zepto and the University of Minnesota launched a study on a multi-fungal detection system.
Zepto started a clinical study with Mayo Clinic for fungal infection diagnostics.
A collaborative study between Zepto Life Technology and the University of Minnesota on improving monitoring of fungal infections.
Zepto announced a critical study presentation at ECCMID in April 2024.
Zepto formed an advisory board with industry experts in infectious diseases and molecular diagnostics.
Zepto announced the successful closing of its Series A funding round from Huimei Healthcare.
Zepto and the University of Minnesota launched a study on a multi-fungal detection system.
Zepto started a clinical study with Mayo Clinic for fungal infection diagnostics.